Contemporary Pediatrics
@contemppeds.bsky.social
Practical Information for Today's Pediatrician
In light of today's #ACIP meeting, Chari Cohen, DrPH, MPH, president of the Hepatitis B Foundation, explains that the foundation is recommending that #infants continue to receive the birth dose of the hepatitis B #vaccine.
Watch:
www.contemporarypediatrics.com/view/hepatit...
Watch:
www.contemporarypediatrics.com/view/hepatit...
December 5, 2025 at 10:17 PM
In light of today's #ACIP meeting, Chari Cohen, DrPH, MPH, president of the Hepatitis B Foundation, explains that the foundation is recommending that #infants continue to receive the birth dose of the hepatitis B #vaccine.
Watch:
www.contemporarypediatrics.com/view/hepatit...
Watch:
www.contemporarypediatrics.com/view/hepatit...
NEW TODAY:
The Centers for Disease Control and Prevention's ACIP has voted to pass a pair of updated recommendations related to the #hepatitis B virus vaccine and timing among infants.
View the exact voting language and how the committee voted, here: www.contemporarypediatrics.com/view/acip-vo...
The Centers for Disease Control and Prevention's ACIP has voted to pass a pair of updated recommendations related to the #hepatitis B virus vaccine and timing among infants.
View the exact voting language and how the committee voted, here: www.contemporarypediatrics.com/view/acip-vo...
December 5, 2025 at 4:21 PM
NEW TODAY:
The Centers for Disease Control and Prevention's ACIP has voted to pass a pair of updated recommendations related to the #hepatitis B virus vaccine and timing among infants.
View the exact voting language and how the committee voted, here: www.contemporarypediatrics.com/view/acip-vo...
The Centers for Disease Control and Prevention's ACIP has voted to pass a pair of updated recommendations related to the #hepatitis B virus vaccine and timing among infants.
View the exact voting language and how the committee voted, here: www.contemporarypediatrics.com/view/acip-vo...
Josh Feder, MD, explains applied behavioral analysis, part of a larger discussion of the recent recommendations from the American Academy of Child and Adolescent Psychiatry (@AACAP) to improve and expand access to #autism care.
Watch the full interview: www.contemporarypediatrics.com/view/joshua-...
Watch the full interview: www.contemporarypediatrics.com/view/joshua-...
December 3, 2025 at 8:47 PM
Josh Feder, MD, explains applied behavioral analysis, part of a larger discussion of the recent recommendations from the American Academy of Child and Adolescent Psychiatry (@AACAP) to improve and expand access to #autism care.
Watch the full interview: www.contemporarypediatrics.com/view/joshua-...
Watch the full interview: www.contemporarypediatrics.com/view/joshua-...
The open-label trial will assess safety, tolerability, pharmacodynamics, and preliminary efficacy in adults before expanding into a pediatric cohort.
#Pediatrics #Immunology #RareDisease #GeneTherapy
READ MORE: www.contemporarypediatrics.com/view/first-p...
#Pediatrics #Immunology #RareDisease #GeneTherapy
READ MORE: www.contemporarypediatrics.com/view/first-p...
December 1, 2025 at 5:09 PM
The open-label trial will assess safety, tolerability, pharmacodynamics, and preliminary efficacy in adults before expanding into a pediatric cohort.
#Pediatrics #Immunology #RareDisease #GeneTherapy
READ MORE: www.contemporarypediatrics.com/view/first-p...
#Pediatrics #Immunology #RareDisease #GeneTherapy
READ MORE: www.contemporarypediatrics.com/view/first-p...
In our latest #puzzler quiz, try to diagnose this 8-year-old girl with a corneal lesion.
View some case details below, then click the link for more information and to make your diagnosis.
Can you diagnose this patient?
View more: www.contemporarypediatrics.com/view/can-you...
View some case details below, then click the link for more information and to make your diagnosis.
Can you diagnose this patient?
View more: www.contemporarypediatrics.com/view/can-you...
November 24, 2025 at 6:28 PM
In our latest #puzzler quiz, try to diagnose this 8-year-old girl with a corneal lesion.
View some case details below, then click the link for more information and to make your diagnosis.
Can you diagnose this patient?
View more: www.contemporarypediatrics.com/view/can-you...
View some case details below, then click the link for more information and to make your diagnosis.
Can you diagnose this patient?
View more: www.contemporarypediatrics.com/view/can-you...
New from the FDA:
The agency accepts Arcutis Biotherapeutics' sNDA application for #roflumilast cream 0.3% (Zoryve) to treat #plaque #psoriasis in children aged 2 to 5 years. #medsky #pedsky
More details to come on contemporarypediatrics.com.
The agency accepts Arcutis Biotherapeutics' sNDA application for #roflumilast cream 0.3% (Zoryve) to treat #plaque #psoriasis in children aged 2 to 5 years. #medsky #pedsky
More details to come on contemporarypediatrics.com.
November 17, 2025 at 2:31 PM
New from the FDA:
The agency accepts Arcutis Biotherapeutics' sNDA application for #roflumilast cream 0.3% (Zoryve) to treat #plaque #psoriasis in children aged 2 to 5 years. #medsky #pedsky
More details to come on contemporarypediatrics.com.
The agency accepts Arcutis Biotherapeutics' sNDA application for #roflumilast cream 0.3% (Zoryve) to treat #plaque #psoriasis in children aged 2 to 5 years. #medsky #pedsky
More details to come on contemporarypediatrics.com.
ICYMI:
J&J has submitted a supplemental Biologics License Application to the FDA for ustekinumab (Stelara), seeking an expanded indication to include children 2 years and older with moderately-to-severely active ulcerative colitis. #pedksy
DETAILS: www.contemporarypediatrics.com/view/j-j-sub...
J&J has submitted a supplemental Biologics License Application to the FDA for ustekinumab (Stelara), seeking an expanded indication to include children 2 years and older with moderately-to-severely active ulcerative colitis. #pedksy
DETAILS: www.contemporarypediatrics.com/view/j-j-sub...
J&J submits sBLA for ustekinumab to treat children with ulcerative colitis 2 years and up | Contemporary Pediatrics
If approved, this UC indication would add to pediatric indications of ustekinumab for psoriasis and active psoriatic arthritis.
www.contemporarypediatrics.com
November 3, 2025 at 3:40 PM
ICYMI:
J&J has submitted a supplemental Biologics License Application to the FDA for ustekinumab (Stelara), seeking an expanded indication to include children 2 years and older with moderately-to-severely active ulcerative colitis. #pedksy
DETAILS: www.contemporarypediatrics.com/view/j-j-sub...
J&J has submitted a supplemental Biologics License Application to the FDA for ustekinumab (Stelara), seeking an expanded indication to include children 2 years and older with moderately-to-severely active ulcerative colitis. #pedksy
DETAILS: www.contemporarypediatrics.com/view/j-j-sub...
Arcutis Biotherapeutics has announced the commercial launch of #roflumilast 0.05% for the treatment of mild-to-moderate atopic dermatitis in children aged 2 to 5 years.
Arcutis stated the topical formulation will be available in pharmacies this week.
www.contemporarypediatrics.com/view/lawrenc...
Arcutis stated the topical formulation will be available in pharmacies this week.
www.contemporarypediatrics.com/view/lawrenc...
October 30, 2025 at 1:26 PM
Arcutis Biotherapeutics has announced the commercial launch of #roflumilast 0.05% for the treatment of mild-to-moderate atopic dermatitis in children aged 2 to 5 years.
Arcutis stated the topical formulation will be available in pharmacies this week.
www.contemporarypediatrics.com/view/lawrenc...
Arcutis stated the topical formulation will be available in pharmacies this week.
www.contemporarypediatrics.com/view/lawrenc...
According to new phase 3 data, #upadacitinib met co-primary endpoints in both Phase 3 trials for non-segmental #vitiligo at week 48, among adults and adolescents. #medsky #pedsky
Full details: www.contemporarypediatrics.com/view/upadaci...
Full details: www.contemporarypediatrics.com/view/upadaci...
Upadacitinib achieves 50% reduction in Total Vitiligo Area Scoring Index at 48 weeks
A pair of phase 3 trials showed that AbbVie's daily upadacitinib 15 mg led to a 50% reduction in T-VASI 50 and a 75% reduction in F-VASI 75 at 48 weeks among adolescents 12 years and older.
www.contemporarypediatrics.com
October 29, 2025 at 4:53 PM
According to new phase 3 data, #upadacitinib met co-primary endpoints in both Phase 3 trials for non-segmental #vitiligo at week 48, among adults and adolescents. #medsky #pedsky
Full details: www.contemporarypediatrics.com/view/upadaci...
Full details: www.contemporarypediatrics.com/view/upadaci...
In this Q&A, Tracey Gaslin PhD, CPNP, FNP-BC, CRNI, RN-BC, of Alliance for Camp Health, talks about #ticks!
Highlights:
- Extended tick activity later into the year
- How pediatricians can educate families on ticks, bites, and post-bite care
Read: www.contemporarypediatrics.com/view/talking...
Highlights:
- Extended tick activity later into the year
- How pediatricians can educate families on ticks, bites, and post-bite care
Read: www.contemporarypediatrics.com/view/talking...
Talking ticks with Tracey Gaslin, PhD, CPNP, FNP-BC, CRNI, RN-BC
In this Q&A, nurse practitioner Tracey Gaslin, PhD, discusses tick bites in pediatric patients, from how to prevent a bite to what to do after a bite, and highlights resources available from the Fight...
www.contemporarypediatrics.com
October 28, 2025 at 6:37 PM
In this Q&A, Tracey Gaslin PhD, CPNP, FNP-BC, CRNI, RN-BC, of Alliance for Camp Health, talks about #ticks!
Highlights:
- Extended tick activity later into the year
- How pediatricians can educate families on ticks, bites, and post-bite care
Read: www.contemporarypediatrics.com/view/talking...
Highlights:
- Extended tick activity later into the year
- How pediatricians can educate families on ticks, bites, and post-bite care
Read: www.contemporarypediatrics.com/view/talking...
In this Q&A discussion, study investigator of zoliflodacin, Sarah McLeod, PhD, highlights phase 3 data on the drug's efficacy against multidrug-resistant Neisseria #gonorrhoeae. #IDWeek #medsky #pedsky
Click here to read this Q&A from #IDWeek:
www.contemporarypediatrics.com/view/sarah-m...
Click here to read this Q&A from #IDWeek:
www.contemporarypediatrics.com/view/sarah-m...
October 27, 2025 at 8:46 PM
In this Q&A discussion, study investigator of zoliflodacin, Sarah McLeod, PhD, highlights phase 3 data on the drug's efficacy against multidrug-resistant Neisseria #gonorrhoeae. #IDWeek #medsky #pedsky
Click here to read this Q&A from #IDWeek:
www.contemporarypediatrics.com/view/sarah-m...
Click here to read this Q&A from #IDWeek:
www.contemporarypediatrics.com/view/sarah-m...
Also new today out of #FallClinical2025 in Vegas:
Lebrikizumab-lbkz (Ebglyss; EliLillyandCo) demonstrated similar levels of #skin clearance in patients with #atopicdermatitis when administered once every 8 weeks compared to every 4 weeks.
MORE: www.contemporarypediatrics.com/view/fall-cl...
Lebrikizumab-lbkz (Ebglyss; EliLillyandCo) demonstrated similar levels of #skin clearance in patients with #atopicdermatitis when administered once every 8 weeks compared to every 4 weeks.
MORE: www.contemporarypediatrics.com/view/fall-cl...
October 24, 2025 at 5:02 PM
Also new today out of #FallClinical2025 in Vegas:
Lebrikizumab-lbkz (Ebglyss; EliLillyandCo) demonstrated similar levels of #skin clearance in patients with #atopicdermatitis when administered once every 8 weeks compared to every 4 weeks.
MORE: www.contemporarypediatrics.com/view/fall-cl...
Lebrikizumab-lbkz (Ebglyss; EliLillyandCo) demonstrated similar levels of #skin clearance in patients with #atopicdermatitis when administered once every 8 weeks compared to every 4 weeks.
MORE: www.contemporarypediatrics.com/view/fall-cl...
Announced at the 2025 @fallclinical #Dermatology Conference in Las Vegas:
Roflumilast cream 0.15% and 0.05% demonstrated improved #itch and reduced impact of AD on sleep in patients 2 years and up. #medsky #pedsky
Full coverage: www.contemporarypediatrics.com/view/fall-cl...
Roflumilast cream 0.15% and 0.05% demonstrated improved #itch and reduced impact of AD on sleep in patients 2 years and up. #medsky #pedsky
Full coverage: www.contemporarypediatrics.com/view/fall-cl...
October 24, 2025 at 4:53 PM
Announced at the 2025 @fallclinical #Dermatology Conference in Las Vegas:
Roflumilast cream 0.15% and 0.05% demonstrated improved #itch and reduced impact of AD on sleep in patients 2 years and up. #medsky #pedsky
Full coverage: www.contemporarypediatrics.com/view/fall-cl...
Roflumilast cream 0.15% and 0.05% demonstrated improved #itch and reduced impact of AD on sleep in patients 2 years and up. #medsky #pedsky
Full coverage: www.contemporarypediatrics.com/view/fall-cl...
The #FDA has expanded pediatric indications for adalimumab-aaty (Yuflyma; Celltrion USA) and unbranded adalimumab-aaty to include the treatment of hidradenitis suppurativa in adolescent patients aged 12 years and older, and uveitis in pediatric patients aged 2 years and older.
October 17, 2025 at 1:49 PM
The #FDA has expanded pediatric indications for adalimumab-aaty (Yuflyma; Celltrion USA) and unbranded adalimumab-aaty to include the treatment of hidradenitis suppurativa in adolescent patients aged 12 years and older, and uveitis in pediatric patients aged 2 years and older.
This week, the Infectious Diseases Society of America released updated guidelines regarding testing for Group A Streptococcal pharyngitis in adolescents and adults. #Strep #Strepthroat #medksy #pediatrics #pedsky
Read more on the updated guideline: www.contemporarypediatrics.com/view/idsa-re...
Read more on the updated guideline: www.contemporarypediatrics.com/view/idsa-re...
IDSA recommends use of scoring systems to guide testing for Group A Streptococcal pharyngitis
IDSA’s new GAS pharyngitis guidance emphasizes selective testing using clinical scoring to reduce overtreatment and antibiotic misuse.
www.contemporarypediatrics.com
October 15, 2025 at 5:10 PM
This week, the Infectious Diseases Society of America released updated guidelines regarding testing for Group A Streptococcal pharyngitis in adolescents and adults. #Strep #Strepthroat #medksy #pediatrics #pedsky
Read more on the updated guideline: www.contemporarypediatrics.com/view/idsa-re...
Read more on the updated guideline: www.contemporarypediatrics.com/view/idsa-re...
Thank you, peace madueme, MD, chief of #Cardiology at @Nemours Children's Hospital in Orlando, Florida, for speaking with us about #ECGs and how they can supplement routine sports physicals for #youth athletes. #medsky
Watch our full interview here: www.contemporarypediatrics.com/view/using-e...
Watch our full interview here: www.contemporarypediatrics.com/view/using-e...
October 14, 2025 at 3:57 PM
Thank you, peace madueme, MD, chief of #Cardiology at @Nemours Children's Hospital in Orlando, Florida, for speaking with us about #ECGs and how they can supplement routine sports physicals for #youth athletes. #medsky
Watch our full interview here: www.contemporarypediatrics.com/view/using-e...
Watch our full interview here: www.contemporarypediatrics.com/view/using-e...
If you missed it:
Today, the FDA accepted MannKind Corporation's sBLA for #Afrezza Inhalation Powder to include children and adolescents with type 1 or type 2 #diabetes.
READ MORE:
www.contemporarypediatrics.com/view/fda-acc...
Today, the FDA accepted MannKind Corporation's sBLA for #Afrezza Inhalation Powder to include children and adolescents with type 1 or type 2 #diabetes.
READ MORE:
www.contemporarypediatrics.com/view/fda-acc...
October 13, 2025 at 6:47 PM
If you missed it:
Today, the FDA accepted MannKind Corporation's sBLA for #Afrezza Inhalation Powder to include children and adolescents with type 1 or type 2 #diabetes.
READ MORE:
www.contemporarypediatrics.com/view/fda-acc...
Today, the FDA accepted MannKind Corporation's sBLA for #Afrezza Inhalation Powder to include children and adolescents with type 1 or type 2 #diabetes.
READ MORE:
www.contemporarypediatrics.com/view/fda-acc...
Backup camera mandate linked to fewer severe pediatric backover injuries: Backover trauma occurs when a pedestrian is struck by a motor vehicle in reverse. Researchers reported both fatal and severe injuries in children under age 5 have decreased. #medsky #pedsky
More:
hubs.li/Q03LwvXw0
More:
hubs.li/Q03LwvXw0
September 30, 2025 at 3:05 PM
Backup camera mandate linked to fewer severe pediatric backover injuries: Backover trauma occurs when a pedestrian is struck by a motor vehicle in reverse. Researchers reported both fatal and severe injuries in children under age 5 have decreased. #medsky #pedsky
More:
hubs.li/Q03LwvXw0
More:
hubs.li/Q03LwvXw0
The study, "The Association of Maternal Adverse Childhood Experiences with Preterm Birth of Their Infants," found that #mothers with 2 or more ACEs were nearly twice as likely to deliver #preterm as those with fewer or no ACEs.
Read more: hubs.li/Q03Lwwht0
Read more: hubs.li/Q03Lwwht0
September 30, 2025 at 3:05 PM
The study, "The Association of Maternal Adverse Childhood Experiences with Preterm Birth of Their Infants," found that #mothers with 2 or more ACEs were nearly twice as likely to deliver #preterm as those with fewer or no ACEs.
Read more: hubs.li/Q03Lwwht0
Read more: hubs.li/Q03Lwwht0
Michael Levas, MD, of Project Ujima and Children's Wisconsin presented data at the 2025 AAP National Conference that demonstrated nearly 1 in 4 children with #firearm injuries had prior #ED visits for crashes or violence. #AAP
More on this association: hubs.li/Q03LwqWB0
More on this association: hubs.li/Q03LwqWB0
September 30, 2025 at 3:04 PM
Michael Levas, MD, of Project Ujima and Children's Wisconsin presented data at the 2025 AAP National Conference that demonstrated nearly 1 in 4 children with #firearm injuries had prior #ED visits for crashes or violence. #AAP
More on this association: hubs.li/Q03LwqWB0
More on this association: hubs.li/Q03LwqWB0
New research published at the 2025 AAP National Conference has revealed an emerging #suicide method that involves the ingestion of sodium nitrite. The method is increasingly being used by adolescents and young adults. #AAP
More on this emerging trend: www.contemporarypediatrics.com/view/sodium-...
More on this emerging trend: www.contemporarypediatrics.com/view/sodium-...
September 30, 2025 at 2:50 PM
New research published at the 2025 AAP National Conference has revealed an emerging #suicide method that involves the ingestion of sodium nitrite. The method is increasingly being used by adolescents and young adults. #AAP
More on this emerging trend: www.contemporarypediatrics.com/view/sodium-...
More on this emerging trend: www.contemporarypediatrics.com/view/sodium-...
In another video interview from the 2025 AAP National Conference & Exhibition, Diane Straub, MD, of Children's Hospital Colorado, discussed the current climate related to adolescent sexual health.
Watch our brief discussion with Straub here: www.contemporarypediatrics.com/view/diane-s...
Watch our brief discussion with Straub here: www.contemporarypediatrics.com/view/diane-s...
September 29, 2025 at 4:42 PM
In another video interview from the 2025 AAP National Conference & Exhibition, Diane Straub, MD, of Children's Hospital Colorado, discussed the current climate related to adolescent sexual health.
Watch our brief discussion with Straub here: www.contemporarypediatrics.com/view/diane-s...
Watch our brief discussion with Straub here: www.contemporarypediatrics.com/view/diane-s...
From the AAP National Conference & Exhibition:
Melanie Cree, MD, discussed approaches to evaluating primary amenorrhea and managing conditions such as Turner syndrome, polycystic ovary syndrome (PCOS), and the female athlete triad.
Full interview: www.contemporarypediatrics.com/view/melanie...
Melanie Cree, MD, discussed approaches to evaluating primary amenorrhea and managing conditions such as Turner syndrome, polycystic ovary syndrome (PCOS), and the female athlete triad.
Full interview: www.contemporarypediatrics.com/view/melanie...
September 29, 2025 at 4:20 PM
From the AAP National Conference & Exhibition:
Melanie Cree, MD, discussed approaches to evaluating primary amenorrhea and managing conditions such as Turner syndrome, polycystic ovary syndrome (PCOS), and the female athlete triad.
Full interview: www.contemporarypediatrics.com/view/melanie...
Melanie Cree, MD, discussed approaches to evaluating primary amenorrhea and managing conditions such as Turner syndrome, polycystic ovary syndrome (PCOS), and the female athlete triad.
Full interview: www.contemporarypediatrics.com/view/melanie...
According to a presentation at the 2025 AAP National Conference & Exhibition in Denver, #opioid exposures among US-children are showing concerning trends, with steady increases in pre-teen cases over the past 5 years. #medsky
Full study details: www.contemporarypediatrics.com/view/emergen...
Full study details: www.contemporarypediatrics.com/view/emergen...
September 26, 2025 at 7:54 PM
According to a presentation at the 2025 AAP National Conference & Exhibition in Denver, #opioid exposures among US-children are showing concerning trends, with steady increases in pre-teen cases over the past 5 years. #medsky
Full study details: www.contemporarypediatrics.com/view/emergen...
Full study details: www.contemporarypediatrics.com/view/emergen...
From the AAP National Conference:
Hands-on menstruation education fosters confidence, reduces stigma, and equips adolescents with practical skills for menstrual health, according to an abstract presented at the conference.
Full study details: www.contemporarypediatrics.com/view/hands-o...
Hands-on menstruation education fosters confidence, reduces stigma, and equips adolescents with practical skills for menstrual health, according to an abstract presented at the conference.
Full study details: www.contemporarypediatrics.com/view/hands-o...
Hands-on menstruation education program improves adolescent preparedness, confidence
Hands-on menstruation education fosters confidence, reduces stigma, and equips adolescents with practical skills for menstrual health.
www.contemporarypediatrics.com
September 26, 2025 at 3:41 PM
From the AAP National Conference:
Hands-on menstruation education fosters confidence, reduces stigma, and equips adolescents with practical skills for menstrual health, according to an abstract presented at the conference.
Full study details: www.contemporarypediatrics.com/view/hands-o...
Hands-on menstruation education fosters confidence, reduces stigma, and equips adolescents with practical skills for menstrual health, according to an abstract presented at the conference.
Full study details: www.contemporarypediatrics.com/view/hands-o...